KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Shares Outstanding (Diluted Average) (2016 - 2025)

Evolent Health (EVH) has 11 years of Shares Outstanding (Diluted Average) data on record, last reported at $115.1 million in Q3 2025.

  • For Q3 2025, Shares Outstanding (Diluted Average) changed 0.19% year-over-year to $115.1 million; the TTM value through Sep 2025 reached $115.1 million, changed 0.19%, while the annual FY2024 figure was $114.7 million, 3.08% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $115.1 million in Q3 2025 per EVH's latest filing, down from $115.9 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $115.9 million in Q2 2025 and bottomed at $84.7 million in Q1 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $103.2 million, with a median of $111.3 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): decreased 0.15% in 2021, then increased 23.93% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $86.1 million in 2021, then grew by 8.87% to $93.7 million in 2022, then grew by 18.73% to $111.3 million in 2023, then increased by 3.08% to $114.7 million in 2024, then rose by 0.35% to $115.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $115.1 million in Q3 2025, $115.9 million in Q2 2025, and $115.3 million in Q1 2025.